Extrapulmonary Neuroendocrine Carcinoma

Extrapulmonary Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

315 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 104
Recruiting: 46
Ph III recruiting: 1
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (50)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05086692	A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1)	recruiting	Phase 1 / Phase 2	115	Medicenna Therapeutics, Inc.INDUSTRY	7	Jul 9, 2025	clinicaltrials
NCT05797415	Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers(BLS)	recruiting	—	25	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER	1	Oct 1, 2024